About Vence
Vence is a company based in San Francisco (United States) founded in 2016 was acquired by Merck Animal Health in September 2022. Vence has raised $14.7 million across 4 funding rounds from investors including Rabobank, Merck Animal Health and FoodBytes. Vence offers products and services including Vence, BOVILIS, BRAVECTO, and NOBIVAC. Vence operates in a competitive market with competitors including Stellapps, Allflex, Herddogg, Nofence and Smartbow, among others.
- Headquarter San Francisco, United States
-
Sectors
TechnologyAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vence Corp
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.7 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Rabobank
& 9 more
-
Employee Count
Not available
-
Acquired by
Merck Animal Health
(Sep 22, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vence
Vence offers a comprehensive portfolio of products and services, including Vence, BOVILIS, BRAVECTO, and NOBIVAC.
System for managing cattle movement with GPS and boundaries
Vaccine products for animal disease prevention
Treatment for parasites in animals
Vaccines for various animal species
Funding Insights of Vence
Vence has successfully raised a total of $14.7M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vence
Vence has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Rabobank, Merck Animal Health and FoodBytes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Shell
|
Locked | Locked | Locked | |
|
Investment arm of Rabobank, focusing on equity capital provision.
|
Locked | Locked | Locked | |
|
Early-stage hardware sector investments are made by Tyche Partners.
|
Locked | Locked | Locked |
Investor details for Vence
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vence
Investment portfolio details for Vence
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vence
Detailed financials for Vence
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vence Comparisons
Peer comparison for Vence
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vence
Vence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stellapps, Allflex, Herddogg, Nofence and Smartbow, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of IoT and software solutions for dairy supply chain optimization
|
|
| Locked | Locked | Locked |
Livestock identification and tracking systems are provided globally.
|
|
| Locked | Locked | Locked |
Integrated hardware and software for livestock monitoring are provided.
|
|
| Locked | Locked | Locked |
Solar-powered digital fencing systems for livestock management are manufactured.
|
|
| Locked | Locked | Locked |
Integrated solution for real-time livestock monitoring
|
Detailed competitors of Vence
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vence
Complete news archive for Vence
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vence
Vence was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Vence is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Vence is a funded company, having raised a total of $14.7M across 4 funding rounds to date.
Founded in 2016 and based in San Francisco, United States, Vence focuses on agricultural technology. An integrated hardware and software platform is offered for livestock management. GPS-enabled collars are provided as wearables, equipped with auditory and electric stimuli to direct animals during grazing. Farms are mapped via the software for optimized planning, while collected data is analyzed to identify diseases and support yield improvements.
Vence offers Vence, BOVILIS, BRAVECTO, and NOBIVAC.
Vence has 10 investors. Key investors include Rabobank, Merck Animal Health, FoodBytes, Shell Ventures, and Rabo Investments.